This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

REGULATORY

NCC Eyes Trial Enrollment of 150 Rare Cancer Patients under Registry Initiative

As the government revs up its bid to support clinical trials by encapsulating a patient registry initiative in its economic and fiscal policy plans, national medical centers creating the system ... > Read full story
REGULATORY
Official Denies Report, Says Govt Won’t Ask Research-Driven Firms to Make Generics (Jul.03)
ORGANIZATION
JPMA Sacks Hasegawa as Vice President after Business Improvement Order (Jul.03)
BUSINESS
MTPC Preparing to Submit Radicut for an Indication of ALS in the US (Jul.03)
REGULATORY
MHLW to Accept Applications for Sakigake Designation for Regenerative Medicine Products, Medical Devices from Sept. 14 (Jul.03)
BUSINESS
Santen Files IND Application for Anti-Endoglin Antibody for Wet AMD in US (Jul.03)
> More Latest News

News Categories

REGULATORY
NCC Eyes Trial Enrollment of 150 Rare Cancer Patients under Registry Initiative(Jul.03)
   Official Denies Report, Says Govt Won’t Ask Research-Driven Firms to Make Generics(Jul.03)
   MHLW to Accept Applications for Sakigake Designation for Regenerative Medicine Products, Medical Devices from Sept. 14(Jul.03)
BUSINESS
   MTPC Preparing to Submit Radicut for an Indication of ALS in the US(Jul.03)
   Santen Files IND Application for Anti-Endoglin Antibody for Wet AMD in US(Jul.03)
   President Tada to Double as Drug Development Head: Sumitomo Dainippon(Jul.03)
ORGANIZATION
   JPMA Sacks Hasegawa as Vice President after Business Improvement Order(Jul.03)
FPMAJ Chair Hails Innovation-Fueling Policies in Govt Fiscal Plan(Jul.02)
   JPMA Announces New Fair Competition Guidelines(Jul.02)
ACADEMIA
   JSGM to Issue Policy Proposal after MHLW Sets New Target for Generic Market Share(Jun.17)
   AGs “Will Energize the Generic Drug Market”: Prof. Sakamaki(Jun.17)
   MHLW Official Urges Generic Drug Makers to Expand into Overseas Markets(Jun.17)

Commentary

Japan Compassionate Use System a “Stick” for Drug Makers? Incentives to Counter Their Burden Needed

Lexicon

Z2 Rule:
Z2(ゼットツー)

The Column

The Mastery of Recruitment

Archives

President Tada to Double as Drug Development Head: Sumitomo Dainippon(Jul.03)
LDP, Komeito Lawmakers’ Group Formed to Fight Hepatitis(Jul.02)
FPMAJ Chair Hails Innovation-Fueling Policies in Govt Fiscal Plan(Jul.02)
JCR Aims at Growth through New Products, Out-Licensing Activities(Jul.02)
JPMA Announces New Fair Competition Guidelines(Jul.02)

News Calendar